ARCTIC Feasibility
The efficacy and safety of two topical antiseptic solutions for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: a feasibility study.
Recruitment
Total: 116
Target: 110
Recruitment to the ARCTIC trial is closed.
We would like to thank all the families and site staff who took part.
Download the ARCTIC Parent Information Leaflet and Consent Form
Publications
ARCTIC Feasibility Trial Results
Clarke P, Soe A, Nichols A, Harizaj H, Webber MA, Linsell L, et al. 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2023:fetalneonatal-2023-325871.
ARCTIC Feasibility Trial Protocol
Clarke P, Craig JV, Wain J, Tremlett C, Linsell L, Bowler U, et al. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol. BMJ open. 2019;9(2):e028022
General Information
- EudraCT No.:
- 2015-000874-36
- REC Reference:
- 15/EE/0345
- ISRCTN:
- 82571474
- Clinical Trials Unit:
- National Perinatal Epidemiology Unit CTU
- Sponsor:
- Norfolk and Norwich University Hospitals
- Funder:
- NIHR Research for Patient Benefit (RfPB) Programme
- Recruitment Target:
- 110
Contact Details
If you would like to contact the trial team, please email ctu@npeu.ox.ac.uk.